Literature DB >> 12810771

Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.

M R Piras1, I Magnano, E D G Canu, K S Paulus, W M Satta, A Soddu, M Conti, A Achene, G Solinas, I Aiello.   

Abstract

OBJECTIVE: (1) To assess cognitive function and cerebral magnetic resonance imaging (MRI) involvement in relapsing-remitting multiple sclerosis; (2) to monitor disease evolution, cognitive dysfunction, and cerebral lesion burden over time (mean 8.5 year follow up period); (3) to study the relation between clinical, neuropsychological, and MRI data. On follow up assessment, visual and auditory oddball event related potentials (ERPs) were recorded as psychophysiological evaluation of cognitive status. Correlations between neuropsychological, MRI, and ERP data were also analysed.
METHODS: Neuropsychological study assessed verbal and non-verbal IQ, deterioration index (DI) from WAIS subtests, conceptual reasoning, attention, verbal and visuospatial short-term and long term memory. MRI assessment detected presence of demyelinating lesions by using a semiquantitative method as well as cortical and subcortical atrophy over time.
RESULTS: Attention, short-term and long term visuospatial memory were mildly impaired at baseline and remained unaltered longitudinally. At retesting a significant worsening of verbal long term memory (p=0.023), DI presence (p=0.041) and the increase of supratentorial and subtentorial MRI lesions load (p=0.001) emerged. Expanded disability status scale score correlated significantly with total lesion burden at both evaluations (p=0.043 and p=0.024 respectively). Temporal, occipital, and frontal horn lesions as well as cortical atrophy correlated significantly with attention and memory tests at baseline. Follow up assessment revealed significant correlation between cortical atrophy and attention as well as visuospatial short-term memory; spatial long term memory correlated significantly with lesions in body of lateral ventricle and frontal lobe. ERP study showed P300 latency abnormalities in 75% of patients, involving specifically more visual P300 (58.4 % of cases) than auditory wave (41.6 %). Visual P300 latency and amplitude correlated significantly with DI and auditory P300 latency with frontal horn and brain stem lesions.
CONCLUSIONS: These findings revealed mild cognitive impairment in MS patients particularly consistent with slowing information processing over time. Increased MRI lesions do not correlate with the clinical course of the disease and cognitive deficit evolution. Thus, cognitive dysfunction could be related to disease peculiarity and not to the time course. Correlations between P300, neuropsychological, and MRI findings provide further information about ERP application to examine cognitive impairment in MS and probably to investigate their neural origin.

Entities:  

Mesh:

Year:  2003        PMID: 12810771      PMCID: PMC1738564          DOI: 10.1136/jnnp.74.7.878

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  59 in total

1.  Cognition in patients with multiple sclerosis After four years.

Authors:  A Jennekens-Schinkel; P M Laboyrie; J B Lanser; E A van der Velde
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

2.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis.

Authors:  M Filippi; C Tortorella; M Rovaris; M Bozzali; F Possa; M P Sormani; G Iannucci; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

3.  Raven's coloured progressive matrices: normative values on 305 adult normal controls.

Authors:  A Basso; E Capitani; M Laiacona
Journal:  Funct Neurol       Date:  1987 Apr-Jun

4.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

5.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

Review 6.  Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.

Authors:  M Filippi; M A Horsfield; P S Tofts; F Barkhof; A J Thompson; D H Miller
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

7.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Authors:  R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

8.  Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

Authors:  M J Hohol; C R Guttmann; J Orav; G A Mackin; R Kikinis; S J Khoury; F A Jolesz; H L Weiner
Journal:  Arch Neurol       Date:  1997-08

9.  Multiple sclerosis: a serial study using MRI in relapsing patients.

Authors:  C Isaac; D K Li; M Genton; C Jardine; E Grochowski; M Palmer; L F Kastrukoff; J Oger; D W Paty
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

10.  Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

Authors:  M Rovaris; M Filippi; M Falautano; L Minicucci; M A Rocca; V Martinelli; G Comi
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  40 in total

Review 1.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

2.  A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?

Authors:  Marina Katsari; Dimitrios S Kasselimis; Erasmia Giogkaraki; Marianthi Breza; Maria-Eleftheria Evangelopoulos; Maria Anagnostouli; Elisabeth Andreadou; Costas Kilidireas; Alia Hotary; Ioannis Zalonis; Georgios Koutsis; Constantin Potagas
Journal:  J Neurol       Date:  2020-02-01       Impact factor: 4.849

3.  Deconstructing spatial working memory and attention deficits in multiple sclerosis.

Authors:  Leon Gmeindl; Susan M Courtney
Journal:  Neuropsychology       Date:  2011-11-07       Impact factor: 3.295

4.  Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis.

Authors:  P L Francis; R Jakubovic; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

5.  Electrophysiological and behavioral effects of frontal transcranial direct current stimulation on cognitive fatigue in multiple sclerosis.

Authors:  Marina Fiene; Katharina S Rufener; Maria Kuehne; Mike Matzke; Hans-Jochen Heinze; Tino Zaehle
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 6.  Neurophysiological correlates of cognitive disturbances in multiple sclerosis.

Authors:  Letizia Leocani; Javier J Gonzalez-Rosa; Giancarlo Comi
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

7.  Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study.

Authors:  S Lori; E Portaccio; V Zipoli; M Giannini; S Scarpelli; B Goretti; M P Amato
Journal:  Neurol Sci       Date:  2011-05-17       Impact factor: 3.307

8.  Ecological Momentary Assessment of Pain, Fatigue, Depressive, and Cognitive Symptoms Reveals Significant Daily Variability in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

9.  Validity of the Verbal Concept Attainment Test in multiple sclerosis.

Authors:  Ryan Mulligan; Michael R Basso; Lily Lau; Bradley Reynolds; Douglas M Whiteside; Dennis Combs; Robert A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2019-01-14       Impact factor: 2.475

Review 10.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.